Basic Information
Basic information for TMEM161B-AS1-203-19aa
Peptide Name TMEM161B-AS1-203-19aa
Genome Position chr5:88436318-88436374[+]
Species Human
Peptide Sequence MSPTTLEANADTGGRFHGS
Peptide Length 19
Unique No (TMEM161B-AS1-202-19aa,TMEM161B-AS1-206-19aa,TMEM161B-AS1-210-19aa,TMEM161B-AS1-213-19aa,TMEM161B-AS1-217-19aa,TMEM161B-AS1-220-19aa,TMEM161B-AS1-224-19aa,TMEM161B-AS1-226-19aa-1,TMEM161B-AS1-242-19aa-1,TMEM161B-AS1-243-19aa,TMEM161B-AS1-259-19aa-1)
Grand Average of Hydropathicity -0.6632
Relative Molecular Mass 2273.46
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000247828;TMEM161B-AS1
Transcript ID/Name ENST00000501869;TMEM161B-AS1-203
Transcript Length 880
Coding Ability 0.4182
DNA Sequence Corresponding to Peptide ATGTCACCGACCACACTGGAGGCCAATGCAGATACTGGGGGAAGGTTCCATGGTAGC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :